Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Clene Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: " ",
" "
08/04/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
06/30/2023 8-K Investor presentation
Docs: " ",
" ",
" "
06/16/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " ",
" ",
" ",
" ",
" ",
" "
06/16/2023 8-K Other Events  Interactive Data
05/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: " ",
" "
04/17/2023 8-K Quarterly results
03/17/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/13/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: " "
03/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
03/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
03/06/2023 8-K Investor presentation
Docs: " "
02/27/2023 8-K Investor presentation
Docs: " "
02/27/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
02/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: " "
12/19/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "AMENDMENT NO. 1 TO EQUITY DISTRIBUTION AGREEMENT"
11/07/2022 8-K Quarterly results
Docs: "Clene Reports Third Quarter 2022 Financial Results and Recent Operating Highlights • Secondary survival endpoint for the CNM-Au8® 30 mg dose investigated in the Healey ALS Platform Trial demonstrated a >90% reduction in the risk of death or death equivalent and risk of death alone at 24 weeks. This survival benefit was consistent with prior results reported from the Phase 2 RESCUE-ALS trial long term open-label extension. • Topline results from the Phase 2 VISIONARY-MS clinical trial of CNM-Au8® met the primary and secondary endpoints of Low Contrast Letter Acuity and global neurological improvement measured by the modified Multiple Sclerosis Functional Composite compared to placebo over 48 weeks in the modified intent to treat population. • Cash, cash equivalents, and..."
10/31/2022 8-K Quarterly results
10/03/2022 8-K Investor presentation
Docs: "Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial • The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24 weeks • Prespecified exploratory analyses of the secondary survival endpoint for the 30 mg dose demonstrated a >90% reduction in risk of death or risk of death/permanently assisted ventilation at 24 weeks • Survival signal consistent with prior results from the Phase 2 RESCUE-ALS trial • Clene will continue the open-label extension of CNM-Au8 in the Healey ALS Platform Trial and is in discussions with the Healey & AMG ALS Center to design and offer an Expanded Access Protocol of CNM-Au8 30mg for eligible participants of closed regimens and others • Clene...",
"Healey ALS Platform Trial CNM-Au8 Results Webcast October 2022 Exhibit 99.2",
"Corporate Presentation October 2022 Exhibit 99.3 Forward Looking Statements This"
09/21/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Evidence for A Survival Benefit with CNM-Au8 Treatment: Interim Results from the RESCUE-ALS Trial Long-Term Open Label Extension Long Term Survival All Randomized"
08/15/2022 8-K Quarterly results
07/21/2022 8-K Quarterly results
07/14/2022 8-K Quarterly results
06/01/2022 8-K Quarterly results
05/19/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
05/06/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/18/2022 8-K Regulation FD Disclosure  Interactive Data
04/14/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "CLENE INC. $50,000,000 equity distribution AGREEMENT"
04/05/2022 8-K Investor presentation
Docs: "Long-Term Survival in OLE Participants:"
03/14/2022 8-K Quarterly results
03/11/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
02/15/2022 8-K Investor presentation
Docs: "Investor Contact",
"Q4 2021 Q3 2021 Q1 2022 Q2 2022 Q3"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy